2 biotech stocks plummet more than 25% after the FDA rejects their drug applications - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

2 biotech stocks plummet more than 25% after the FDA rejects their drug applications

for its hemophilia A gene therapy valoctocogene roxaparvovec. The FDA is requesting more data on the durability of the drug candidate with its primary endpoint being annualized bleeding rate.

The expected timeline of when BioMarin will have the data the FDA is requesting in its CRL will be in late 2021 or early 2022, based on when the last patient will complete the two-year follow-up to its ongoing phase 3 study.Markets InsiderSomething is loading.By clicking ‘Sign up’, you agree to receive marketing emails from Business Insider as well as other partner offers and accept our

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Do You Want To create 3d Amazing Video Intro Logo Animation Video In $5 ? Contact Me : LogoAnimation MadeOnFiverr Top Logo Animation Best Logo Animation

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 729. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Inside the French Riviera's pandemic party problem - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Houston we have a problem.... or in this case, France. 25 guys and only one woman, huge problem.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Stock market news today: Stocks mixed after S&P 500 record close - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Maersk Q2 earnings: World's biggest shipping firm's profits rise 25% - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Stocks to buy, 5 companies set for gains as the economy reopens - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Stock picks to buy, 7 back-to-school firms for big returns: Jefferies - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

US stocks will outperform their global peers, driven by tech, says JPM - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »